I really miss kbin… 😔(no hard feelings, I genuinely wish Ernest the best and hope he makes a comeback)

I actually tried migrating my account from there before the major issues, as a backup, but realised it didn’t back up my blocked lists, which are much harder for me to recreate than my subscribed list and settings are, so decided to wait and see if anyone improved the migration tools.

Then it became too late, and I had to start from scratch, and am now regretting the instance I chose, and have not yet had the brain space to check out the other kbin/mbin instances and find a new one I like. Until then I’m reluctant to participate.

If anything, the last couple of months, with kbin dying and realising how uncomfortable I am on an instance run by people who have expectations from their users I fundamentally disagree with, have made me want to start my own private kbin/mbin instance for myself so that I don’t end up in either situation again, but I don’t know that it’s something I can take on, having no programming knowledge or any experience with anything like that.

So yes, I agree with you, for more than the reasons you’ve provided, and I hope we, as a general community use these developments to learn and improve.

I understand they need to recoup research costs, but…

Except they don’t even need to do that, because, as is with most pharmaceuticals, the research was almost fully funded by the taxpayer.

And the 30% profit is for a generic product, so the research has already been done.

So yeah, 30% profit is of course much better than 3000%, but both are still obscene profiteering off of a lifesaving product paid for by, and then essentially withheld for ransom from, the general public.